TGTX
Tg Therapeutics Inc Earnings
$36.73
Earnings Summary
Revenue | $120.86Mn |
Net Profits | $5.06Mn |
Net Profit Margins | 4.19% |
PE Ratio | 146.88 |
Tg Therapeutics Inc’s revenue jumped 90.4% since last year same period to $120.86Mn in the Q1 2025. On a quarterly growth basis, Tg Therapeutics Inc has generated 11.71% jump in its revenue since last 3-months.
Tg Therapeutics Inc’s net profit jumped 147.26% since last year same period to $5.06Mn in the Q1 2025. On a quarterly growth basis, Tg Therapeutics Inc has generated -78.31% fall in its net profits since last 3-months.
Tg Therapeutics Inc’s net profit margin jumped 124.82% since last year same period to 4.19% in the Q1 2025. On a quarterly growth basis, Tg Therapeutics Inc has generated -80.59% fall in its net profit margins since last 3-months.
Tg Therapeutics Inc’s price-to-earnings ratio after this Q1 2025 earnings stands at 146.88.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.2 |
EPS Estimate Current Year | 0.2 |
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.2 - a 14.94% jump from last quarter’s estimates.
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.2.
Key Ratios
Earning Per Share (EPS) | 0 |
Tg Therapeutics Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q2 2025. This indicates that the Tg Therapeutics Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-05 | 0.2 | 0 | -100% |
2025-05-09 | 0.17 | 0.03 | -82.76% |
